Oncologist France - Dr CANOVA Charles-Henry MD

Residency and Fellowship
I was Chief Resident at the Pitié Salpêtrière Hospital in the Radiation-Oncology Department of Pr Maingon Philippe. (2016-2018)
Radiation Oncology Residency performed in Paris in four big centers for five years.
May 2016 - November 2016, 10th semester in Brachytherapy: Gustave ROUSSY (Pr. DEUTSCH/Dr. HAIE-MEDER)
November 2014 - May 2015, 9th semester in Nuclear Medicine: European Hospital George Pompidou (Pr WEINMANN)
May 2015 - November 2015, 8th semester in Radiation Oncology: GUSTAVE ROUSSY (Pr. DEUTSCH)
November 2014 - May 2015, 7th semester in Medical Resuscitation: PITIE SALPETRIERE Hospital (Pr. SIMILOWSKI)
May 2014 - November 2014, 6th semester in Medical Oncology in Phase 1 therapeutic trials: GUSTAVE ROUSSY (Pr. SORIA)
November 2013 - May 2014, 5th semester in Radiation Oncology: GUSTAVE ROUSSY (Pr. DEUTSCH)
May 2013 - October 2013, 4th semester in Medical Oncology: European Hospital George Pompidou (Pr. OUDARD)
November 2012 - April 2013, the 3rd semester in Radiation Oncology: CURIE Institute (Dr. FOURQUET)
May 2012 - October 2012 2nd semester in Medical Oncology: PITIE SALPETRIERE Hospital (Pr KHAYAT)
November 2011 - April 2012 1st semester in Radiation Oncology: PITIE SALPETRIERE Hospital (Pr MAZERON)
Scientific training
2006-2007: Master 1 (M1) UEs: Anatomy of skull pairs / Immunology
2013-2014: Certificate of Radiotherapy for head and neck cancers in Gustave Roussy
2014-2015: Certificate of Intra- and extra-cranial radiosurgery and stereotactic radiotherapy at Tenon Hospital

2015-2017: Capacity in Medical Oncology
September 2017: ESTRO training in intra-and extracranial stereotactic radiation therapy and Evidence Based Medicine in 2019
Last publications :
  1. Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group. Reboux PA, Azaïs H, Canova CH, Bendifallah S, Ouldamer L, Raimond E, Hudry D, Coutant C, Graesslin O, Touboul C, Collinet P, Bricou A, Huchon C, Daraï E, Ballester M, Lévêque J, Lavoué V, Koskas M, Uzan C, Canlorbe G. J Gynecol Oncol. 2019 Jul;30(4):e53. doi: 10.3802/jgo.2019.30.e53. Epub 2019 Feb 7.
  2. Prognostic factors in patients with soft palate squamous cell carcinoma. Schernberg A, Canova C, Blanchard P, Gorphe P, Breuskin I, Mirghani H, Moya-Plana A, Janot F, Bidault F, Chargari C, Bellefqih S, Ruffier A, Even C, Nguyen F, Temam S, Tao Y. Head Neck. 2019 May;41(5):1441-1449. doi: 10.1002/hed.25598. Epub 2019 Jan 12.
  3. Stereotactic Radiation Therapy for Renal Cell Carcinoma Brain Metastases in the Tyrosine Kinase Inhibitors Era: Outcomes of 120 Patients. Klausner G1, Troussier I2, Biau J3, Jacob J4, Schernberg A5, Canova CH4, Simon JM4, Borius PY6, Malouf G7, Spano JP7, Roupret M8, Cornu P6, Mazeron JJ4, Valéry C6, Feuvret L4, Maingon P4.
  4. Others: https://www.ncbi.nlm.nih.gov/pubmed/?term=canova+ch
Clinical Research :
Co-investigator in the HALT EORTC trial (oligoprogressive lung cancers under TKI)
Co-Investigator of the GORTEC post-op stereo trial
Member of GORTEC, ESMO, and ESTRO
ICH GCP training: completed on 05/07/2017
Languages :
English: oral and written



There are no comments to display
You can leave a comment. Your e-mail will not be published.